1. |
李贺, 郑荣寿, 张思维, 等. 2014 年中国女性乳腺癌发病与死亡分析. 中华肿瘤杂志, 2018, 40(3): 166-171.
|
2. |
师金, 梁迪, 李道娟, 等. 全球女性乳腺癌流行情况研究. 中国肿瘤, 2017, 26(9): 683-690.
|
3. |
马丹丹, 刘坤, 齐晓伟. 2018 年全球癌症统计: 乳腺癌发病和死亡人数统计. 中华乳腺病杂志: 电子版, 2018, 12(6): 375.
|
4. |
Lyman GH, Dale DC, Crawford J. Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices. J Clin Oncol, 2003, 21(24): 4524-4531.
|
5. |
高瑗, 原新. 中国老年人口健康转移与医疗支出. 人口研究, 2020, 44(2): 60-72.
|
6. |
陈万青, 郑荣寿. 中国女性乳腺癌发病死亡和生存状况. 中国肿瘤临床, 2015, 42(13): 668-674.
|
7. |
刘思业, 陈茂山, 杨光伦. 老年乳腺癌的特征及诊治研究进展. 中国普外基础与临床杂志, 2017, 24(4): 518-524.
|
8. |
Muss HB, Woolf S, Berry D, et al. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA, 2005, 293(9): 1073-1081.
|
9. |
Jung SP, Lee JE, Lee SK, et al. Adjuvant chemotherapy and survival of elderly korean patients with breast carcinoma. J Breast Cancer, 2012, 15(3): 296-305.
|
10. |
Begg CB, Cohen JL, Ellerton J. Are the elderly predisposed to toxicity from cancer chemotherapy? An investigation using data from the Eastern Cooperative Oncology Group. Cancer Clin Trials, 1980, 3(4): 369-374.
|
11. |
Dees EC, O’Reilly S, Goodman SN, et al. A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer. Cancer Invest, 2000, 18(6): 521-529.
|
12. |
Hamelinck VC, Bastiaannet E, Pieterse AH, et al. A prospective comparison of younger and older patients’ preferences for adjuvant chemotherapy and hormonal therapy in early breast cancer. Clin Breast Cancer, 2016, 16(5): 379-388.
|
13. |
Singh R, Hellman S, Heimann R. The natural history of breast carcinoma in the elderly: implications for screening and treatment. Cancer, 2004, 100(9): 1807-1813.
|
14. |
Fargeot P, Bonneterre J, Roché H, et al. Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial. J Clin Oncol, 2004, 22(23): 4622-4630.
|
15. |
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet, 2005, 365(9472): 1687-1717.
|
16. |
Inwald EC, Ortmann O, Koller M, et al. Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology. Breast Cancer Res Treat, 2017, 163(1): 119-130.
|
17. |
Leinert E, Singer S, Janni W, et al. The impact of age on quality of life in breast cancer patients receiving adjuvant chemotherapy: a comparative analysis from the prospective multicenter randomized ADEBAR trial. Clin Breast Cancer, 2017, 17(2): 100-106.
|
18. |
Mariano C, Lund JL, Peacock Hinton S, et al. Evaluating the association between adjuvant chemotherapy and function-related adverse events among older patients with early stage breast cancer. J Geriatr Oncol, 2017, 8(4): 242-248.
|
19. |
Muss HB, Polley MC, Berry DA, et al. Randomized trial of standard adjuvant chemotherapy regimens versus capecitabine in older women with early breast cancer: 10-year update of the CALGB 49907 trial. J Clin Oncol, 2019, 37(26): 2338-2348.
|
20. |
吕青, 陈洁. 对老年乳腺癌术后辅助化疗的再认识. 中国普外基础与临床杂志, 2013, 20(8): 833-837.
|
21. |
Clegg A, Young J, Iliffe S, et al. Frailty in elderly people. Lancet, 2013, 381(9868): 752-762.
|
22. |
Rockwood K, Fox RA, Stolee P, et al. Frailty in elderly people: an evolving concept. CMAJ, 1994, 150(4): 489-495.
|
23. |
Mandelblatt JS, Cai L, Luta G, et al. Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance). Breast Cancer Res Treat, 2017, 164(1): 107-117.
|
24. |
Extermann M, Leeuwenburgh C, Samiian L, et al. Impact of chemotherapy on medium-term physical function and activity of older breast cancer survivors, and associated biomarkers. J Geriatr Oncol, 2017, 8(1): 69-75.
|
25. |
Dalmasso B, Hatse S, Brouwers B, et al. Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy. BMC Cancer, 2018, 18(1): 1014.
|
26. |
Bailur JK, Pawelec G, Hatse S, et al. Immune profiles of elderly breast cancer patients are altered by chemotherapy and relate to clinical frailty. Breast Cancer Res, 2017, 19(1): 20.
|
27. |
Aaldriks AA, Giltay EJ, le Cessie S, et al. Prognostic value of geriatric assessment in older patients with advanced breast cancer receiving chemotherapy. Breast, 2013, 22(5): 753-760.
|
28. |
中国痴呆与认知障碍指南写作组, 中国医师协会神经内科医师分会认知障碍疾病专业委员会. 2018 中国痴呆与认知障碍诊治指南(一): 痴呆及其分类诊断标准. 中华医学杂志, 2018, 98(13): 965-970.
|
29. |
Leinert E, Schwentner L, Blettner M, et al. Association between cognitive impairment and guideline adherence for application of chemotherapy in older patients with breast cancer: results from the prospective multicenter BRENDA Ⅱ study. Breast J, 2019, 25(3): 386-392.
|
30. |
Gregorowitsch ML, Ghedri A, Young-Afat DA, et al. The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients. Breast Cancer Res Treat, 2019, 175(2): 429-441.
|
31. |
Chen BT, Sethi SK, Jin T, et al. Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study. Breast Cancer Res, 2018, 20(1): 38.
|
32. |
Freedman RA, Pitcher B, Keating NL, et al. Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907. Breast Cancer Res Treat, 2013, 139(2): 607-616.
|
33. |
邬沧萍. 提高对老年人生活质量的科学认识. 人口研究, 2002, 26(5): 1-5.
|
34. |
Hurria A, Soto-Perez-de-Celis E, Allred JB, et al. Functional decline and resilience in older women receiving adjuvant chemotherapy for breast cancer. J Am Geriatr Soc, 2019, 67(5): 920-927.
|
35. |
Brouwers B, Hatse S, Dal Lago L, et al. The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters. Oncotarget, 2016, 7(21): 29977-29988.
|
36. |
Quinten C, Kenis C, Hamaker M, et al. The effect of adjuvant chemotherapy on symptom burden and quality of life over time; a preliminary prospective observational study using individual data of patients aged ≥70 with early stage invasive breast cancer. J Geriatr Oncol, 2018, 9(2): 152-162.
|